USANA Health Sciences Faces Market Risk with Uncertain Hiya Acquisition Benefits

USANA Health Sciences Inc (USNA) has disclosed a new risk, in the Corporate Activity and Growth category.

USANA Health Sciences Inc. faces a potential risk with the Hiya Acquisition, as it is currently not accretive to the company’s earnings per share on a GAAP basis. The expected timeline for the acquisition to become accretive may not be achieved, which could hinder the realization of anticipated benefits and result in continued dilution of earnings per share. These factors may negatively impact the market price of USANA’s common stock, as investors may react unfavorably to prolonged inefficiencies or delays. The overall uncertainty surrounding the acquisition’s financial benefits poses a tangible risk to the company’s market valuation.

Overall, Wall Street has a Hold consensus rating on USNA stock based on 2 Holds.

To learn more about USANA Health Sciences Inc’s risk factors, click here.